Continuous stimulation of human glucagon-like peptide-1 (7–36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes

Diabetologia ◽

10.1007/s00125-007-0737-6 ◽

2007 ◽

Vol 50 (9) ◽

pp. 1900-1909 ◽

Author(s):

J. Zhang ◽

Y. Tokui ◽

K. Yamagata ◽

J. Kozawa ◽

K. Sayama ◽

...

Keyword(s):

Type 1 Diabetes ◽

Mouse Model ◽

Continuous Stimulation ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Download Full-text

Faculty Opinions recommendation of Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8727957.11798054 ◽

2011 ◽

Author(s):

Kyong Soo Park ◽

Soo Heon Kwak

Keyword(s):

Type 1 Diabetes ◽

Blood Glucose ◽

Blood Glucose Level ◽

Rat Model ◽

Renal Injury ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Inflammatory Action

Download Full-text

Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review

Diabetes Obesity and Metabolism ◽

10.1111/dom.12911 ◽

2017 ◽

Vol 19 (7) ◽

pp. 915-925 ◽

Author(s):

Anders Albèr ◽

Andreas Brønden ◽

Filip K. Knop

Keyword(s):

Type 1 Diabetes ◽

Insulin Therapy ◽

Short Acting ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Role of Glucagon-like peptide-1 “Liraglutide” in Management of Type 1 Diabetes

International Journal of Pharmaceutical and Phytopharmacological Research ◽

10.51847/skbdqro7ng ◽

2021 ◽

Vol 11 (1) ◽

pp. 89-93

Keyword(s):

Type 1 Diabetes ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2018.1519547 ◽

2018 ◽

Vol 19 (15) ◽

pp. 1655-1661 ◽

Author(s):

Sheila A. Doggrell

Keyword(s):

Type 1 Diabetes ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Glucagon-like peptide 1 improved glycemic control in type 1 diabetes

BMC Endocrine Disorders ◽

10.1186/1472-6823-3-3 ◽

2003 ◽

Vol 3 (1) ◽

Author(s):

Margaret T Behme ◽

John Dupré ◽

Thomas J McDonald

Keyword(s):

Type 1 Diabetes ◽

Glycemic Control ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Diabetes Therapy ◽

10.1007/s13300-017-0282-3 ◽

2017 ◽

Vol 8 (4) ◽

pp. 727-738 ◽

Author(s):

Weihao Wang ◽

Hongyan Liu ◽

Shumin Xiao ◽

Shuaihui Liu ◽

Xin Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Vitamin C Further Improves the Protective Effect of Glucagon-Like Peptide-1 on Acute Hypoglycemia-Induced Oxidative Stress, Inflammation, and Endothelial Dysfunction in Type 1 Diabetes

Diabetes Care ◽

10.2337/dc13-0750 ◽

2013 ◽

Vol 36 (12) ◽

pp. 4104-4108 ◽

Author(s):

A. Ceriello ◽

A. Novials ◽

E. Ortega ◽

S. Canivell ◽

L. La Sala ◽

...

Keyword(s):

Oxidative Stress ◽

Type 1 Diabetes ◽

Endothelial Dysfunction ◽

Vitamin C ◽

Protective Effect ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Acute Hypoglycemia

Download Full-text

Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls

Annals of Clinical Biochemistry International Journal of Laboratory Medicine ◽

10.1177/0004563214544709 ◽

2015 ◽

Vol 52 (2) ◽

pp. 220-225 ◽

Author(s):

Karin Zibar ◽

Jadranka Knežević Ćuća ◽

Kristina Blaslov ◽

Tomislav Bulum ◽

Lea Smirčić-Duvnjak

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Healthy Controls ◽

C Peptide ◽

Negative Type ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

Diabetologia ◽

10.1007/s00125-010-2028-x ◽

2011 ◽

Vol 54 (4) ◽

pp. 965-978 ◽

Author(s):

R. Kodera ◽

K. Shikata ◽

H. U. Kataoka ◽

T. Takatsuka ◽

S. Miyamoto ◽

...

Keyword(s):

Type 1 Diabetes ◽

Blood Glucose ◽

Blood Glucose Level ◽

Rat Model ◽

Renal Injury ◽

Receptor Agonist ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Inflammatory Action

Download Full-text

The effect of glucagon-like peptide-1 on the secretion of cholecystokinin and gastrin in patients with type-1 diabetes and healthy subjects

European Journal of Internal Medicine ◽

10.1016/j.ejim.2013.08.274 ◽

2013 ◽

Vol 24 ◽

pp. e108-e109

Author(s):

M. Asmar ◽

A. Asmar ◽

M. Bache ◽

FK. Knop ◽

S. Madsbad ◽

...

Keyword(s):

Type 1 Diabetes ◽

Healthy Subjects ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text